TY - JOUR
T1 - Outcomes and predictors of left ventricle recovery in patients with severe left ventricular dysfunction undergoing transcatheter aortic valve implantation
AU - Witberg, Guy
AU - Levi, Amos
AU - Talmor-Barkan, Yeela
AU - Barbanti, Marco
AU - Valvo, Roberto
AU - Costa, Giuliano
AU - Frittitta, Valentina
AU - De Backer, Ole
AU - Willemen, Yannick
AU - van Der Dorpel, Mark
AU - Mon, Matias
AU - Sugiura, Atsushi
AU - Sudo, Mitsumasa
AU - Masiero, Giulia
AU - Pancaldi, Edoardo
AU - Arzamendi, Dabit
AU - Santos-Martinez, Sandra
AU - Baz, Jose A.
AU - Steblovnik, Klemen
AU - Mauri, Victor
AU - Adam, Matti
AU - Wienemann, Hendrik
AU - Zahler, David
AU - Hein, Manuel
AU - Ruile, Philipp
AU - Aodha, Brídóg Nic
AU - Grasso, Carmelo
AU - Branca, Luca
AU - Estévez-Loureiro, Rodrigo
AU - Amat-Santos, Ignacio J.
AU - Mylotte, Darren
AU - Bunc, Matjaz
AU - Tarantini, Giuseppe
AU - Nombela-Franco, Luis
AU - Sondergaard, Lars
AU - Van Mieghem, Nicolas M.
AU - Finkelstein, Ariel
AU - Kornowski, Ran
N1 - Publisher Copyright:
© 2024 Europa Group. All rights reserved.
PY - 2024/4
Y1 - 2024/4
N2 - BACKGROUND: Data on the likelihood of left ventricle (LV) recovery in patients with severe LV dysfunction and severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and its prognostic value are limited. AIMS: We aimed to assess the likelihood of LV recovery following TAVI, examine its association with midterm mortality, and identify independent predictors of LV function. METHODS: In our multicentre registry of 17 TAVI centres in Western Europe and Israel, patients were stratified by baseline LV function (ejection fraction [EF] >/≤30%) and LV response: no LV recovery, LV recovery (EF increase ≥10%), and LV normalisation (EF ≥50% post-TAVI). RESULTS: Our analysis included 10,872 patients; baseline EF was ≤30% in 914 (8.4%) patients and >30% in 9,958 (91.6%) patients. The LV recovered in 544 (59.5%) patients, including 244 (26.7%) patients whose LV function normalised completely (EF >50%). Three-year mortality for patients without severe LV dysfunction at baseline was 29.4%. Compared to this, no LV recovery was associated with a significant increase in mortality (adjusted hazard ratio 1.32; p<0.001). Patients with similar LV function post-TAVI had similar rates of 3-year mortality, regardless of their baseline LV function. Three variables were associated with a higher likelihood of LV recovery following TAVI: no previous myocardial infarction (MI), estimated glomerular filtration rate >60 mL/min, and mean aortic valve gradient (mAVG) (expressed either as a continuous variable or as a binary variable using the standard low-flow, low-gradient aortic stenosis [AS] definition). CONCLUSIONS: LV recovery following TAVI and the extent of this recovery are major determinants of midterm mortality in patients with severe AS and severe LV dysfunction undergoing TAVI. Patients with no previous MI and those with an mAVG >40 mmHg show the best results following TAVI, which are at least equivalent to those for patients without severe LV dysfunction.
AB - BACKGROUND: Data on the likelihood of left ventricle (LV) recovery in patients with severe LV dysfunction and severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and its prognostic value are limited. AIMS: We aimed to assess the likelihood of LV recovery following TAVI, examine its association with midterm mortality, and identify independent predictors of LV function. METHODS: In our multicentre registry of 17 TAVI centres in Western Europe and Israel, patients were stratified by baseline LV function (ejection fraction [EF] >/≤30%) and LV response: no LV recovery, LV recovery (EF increase ≥10%), and LV normalisation (EF ≥50% post-TAVI). RESULTS: Our analysis included 10,872 patients; baseline EF was ≤30% in 914 (8.4%) patients and >30% in 9,958 (91.6%) patients. The LV recovered in 544 (59.5%) patients, including 244 (26.7%) patients whose LV function normalised completely (EF >50%). Three-year mortality for patients without severe LV dysfunction at baseline was 29.4%. Compared to this, no LV recovery was associated with a significant increase in mortality (adjusted hazard ratio 1.32; p<0.001). Patients with similar LV function post-TAVI had similar rates of 3-year mortality, regardless of their baseline LV function. Three variables were associated with a higher likelihood of LV recovery following TAVI: no previous myocardial infarction (MI), estimated glomerular filtration rate >60 mL/min, and mean aortic valve gradient (mAVG) (expressed either as a continuous variable or as a binary variable using the standard low-flow, low-gradient aortic stenosis [AS] definition). CONCLUSIONS: LV recovery following TAVI and the extent of this recovery are major determinants of midterm mortality in patients with severe AS and severe LV dysfunction undergoing TAVI. Patients with no previous MI and those with an mAVG >40 mmHg show the best results following TAVI, which are at least equivalent to those for patients without severe LV dysfunction.
KW - aortic stenosis
KW - depressed left ventricular function
KW - TAVI
UR - http://www.scopus.com/inward/record.url?scp=85190903657&partnerID=8YFLogxK
U2 - 10.4244/EIJ-D-23-00948
DO - 10.4244/EIJ-D-23-00948
M3 - Article
C2 - 38629416
AN - SCOPUS:85190903657
SN - 1774-024X
VL - 20
SP - E487-E495
JO - EuroIntervention
JF - EuroIntervention
IS - 8
ER -